Ripal Gaudana
- Pharmaceutical Science top 0.2%
- Public Health, Environmental and Occupational Health top 2%
- Molecular Biology
- Ophthalmology top 1%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Ashim K. MitraAshwin C. ParenkyHari Krishna AnanthulaSai H. S. BodduSwapan SamantaAshaben PatelVarun KhuranaMitan Gokulgandhi
- Topics
- Advanced Drug Delivery Systems (6 papers)Protein purification and stability (5 papers)Nanoparticle-Based Drug Delivery (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of PharmaceuticsPharmaceutical Research
- Partner nations
- United StatesIndiaUnited Arab Emirates
In The Last Decade
Ripal Gaudana
14 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 869
- Public Health, Environmental and Occupational Health 713
- Molecular Biology 469
- Ophthalmology 443
- Radiology, Nuclear Medicine and Imaging 416
Countries citing papers authored by Ripal Gaudana
This map shows the geographic impact of Ripal Gaudana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ripal Gaudana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ripal Gaudana more than expected).
Fields of papers citing papers by Ripal Gaudana
This network shows the impact of papers produced by Ripal Gaudana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ripal Gaudana. The network helps show where Ripal Gaudana may publish in the future.
Co-authorship network of co-authors of Ripal Gaudana
This figure shows the co-authorship network connecting the top 25 collaborators of Ripal Gaudana. A scholar is included among the top collaborators of Ripal Gaudana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ripal Gaudana. Ripal Gaudana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 40 | |
| 3 | Development Of A Novel Nanoparticulate Based Formulation Of Antibody-polysaccharide HIP Complex | 1 |
| 4 | 3 | |
| 5 | 30 | |
| 6 | 27 | |
| 7 | 22 | |
| 8 | Ocular Drug Deliverybreakdown → | 999 |
| 9 | 5 | |
| 10 | Development and Evaluation of Dexamethasone Prodrugs for the Treatment of Ocular Ailments | 1 |
| 11 | 3 | |
| 12 | 38 | |
| 13 | 426 | |
| 14 | 26 |
About Ripal Gaudana
Ripal Gaudana is a scholar working on Pharmaceutical Science, Ophthalmology and Biomaterials, having authored 14 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), Protein purification and stability (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Pharmaceutical Science (869 citations), Ophthalmology (443 citations) and Public Health, Environmental and Occupational Health (713 citations). Ripal Gaudana has collaborated with scholars based in United States, India and United Arab Emirates. Frequent co-authors include Ashim K. Mitra, Ashwin C. Parenky, Hari Krishna Ananthula, Sai H. S. Boddu, Ashim K. Mitra, Swapan Samanta, Ashaben Patel, Varun Khurana, Ashim K. Mitra and Mitan Gokulgandhi. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.